1. Home
  2. IDYA vs KLIC Comparison

IDYA vs KLIC Comparison

Compare IDYA & KLIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$31.40

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo Kulicke and Soffa Industries Inc.

KLIC

Kulicke and Soffa Industries Inc.

HOLD

Current Price

$61.90

Market Cap

3.3B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDYA
KLIC
Founded
2015
1951
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.3B
IPO Year
2019
2004

Fundamental Metrics

Financial Performance
Metric
IDYA
KLIC
Price
$31.40
$61.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
3
Target Price
$51.21
$54.67
AVG Volume (30 Days)
824.6K
499.4K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
1.27%
EPS Growth
61.90
100.32
EPS
N/A
0.32
Revenue
$218,710,000.00
$654,081,000.00
Revenue This Year
N/A
$45.04
Revenue Next Year
$191.08
$11.95
P/E Ratio
N/A
$202.31
Revenue Growth
3024.43
N/A
52 Week Low
$13.45
$26.63
52 Week High
$39.28
$77.50

Technical Indicators

Market Signals
Indicator
IDYA
KLIC
Relative Strength Index (RSI) 44.31 41.61
Support Level $29.15 $61.28
Resistance Level $35.47 $72.90
Average True Range (ATR) 1.47 2.72
MACD -0.26 -0.43
Stochastic Oscillator 30.38 3.44

Price Performance

Historical Comparison
IDYA
KLIC

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About KLIC Kulicke and Soffa Industries Inc.

Kulicke & Soffa Industries Inc. is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments, which include Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.

Share on Social Networks: